In The News                     

Feature Story

Substitute Drug Fills Gap Left By Leucovorin Shortage
At the end of April, the FDA approved a substitute for leucovorin, a much-anticipated release during the ongoing shortage of the chemotherapy antidote. Fusilev, manufactured by Spectrum Pharmaceuticals, is a “ready-to-use” formulation of levoleucovorin for injection. The drug is used to treat the side effects of chemotherapy in patients with advanced colon cancer.

Read more about Fusilev.

Other News

Breast Cancer Drug Pushes CRC Cells to Their Death

Flex Sig Misses More Colorectal Cancers than Colonoscopy

Zaltrap Drug Meets Goal - Improves Survival 
 
 

 CCA Spotlight                     

Grab the Family and Meet Us at the National Conference 

A diagnosis of colon cancer affects the entire family. That's why we're headed to Denver, CO to host the Family Matters: What Every Family Needs to Know about Colon Cancer national conference on June 23-24.

We'll be presenting informative sessions for patients, caregivers and children on topics that matter to you. Learn about parenting, intimacy issues, how to support and effectively communicate with one another, as well as the latest on treatments, clinical trials and more. Check out the complete agenda on our website. The registration deadline is June 22. Sign up today! 

New Undy 5000 Incentive Program. Get Your Goodies! 

As if you needed another reason to run in your undies! We are pleased to announce the new, expanded Undy 5000 incentive program. Fundraisers will get to choose from a variety of exciting prizes, ranging from Undy 5000 fashion apparel to the latest in technology. These new items will be available beginning with the 2011 Denver Undy 5000 being held on June 25. View the Undy 5000 incentive page to learn more about this program and check out the new prizes.

Understanding and Navigating Clinical Trials Webinar Replay

If you missed our latest webinar, don’t worry. You can watch a replay at your leisure. Representatives from EmergingMed explain what clinical trials are, which ones are right for you, why you should participate, as well as provide an overview of the new Colorectal Cancer Clinical Trials Matching Service, which matches you with trials based on your specific diagnosis and treatment history.

 Get Involved                       

Volunteers Needed: Take Action Now

We asked and you answered. You voted Joe Boxer as the company you’d like to see as the 2012 Underwear Sponsor for the Undy 5000 5K series. Now we need your help extending this invitation—our many voices combined are very powerful. It’s easy! Just click here to send a message directly to Joe Boxer. Help us get the word out. Invite your friends and family to speak up too!

 Upcoming Events                                    

June 22 - Registration Deadline for National Conference - Register Now!

June 23-24; Denver, CO - CCA National Conference

June 25 - Denver Undy 5000

July 23 - Jersey Shore Undy 5000

August 3; 8 pm ET - Tele-Chat: Update from the ASCO Annual Meeting

August 20 - Tacoma Undy 5000 

Please visit our Blue Star Calendar for a complete listing of events. 

www.ccalliance.org | (877) 422-2030

JOIN OUR CAUSE

The Colon Cancer Alliance is committed to ending the suffering and death caused by colorectal cancer.
The Colon Cancer Alliance, Inc. is a not-for-profit 501( c ) 3 corporation.

Colon Cancer Alliance, Inc., 1025 Vermont Ave., NW, Ste 1066, Washington, DC 20005

View this message as HTML in your browser.

Forward this message.

This email was sent to . Unsubscribe or change your email preferences.